Infused undergarment

Information

  • Patent Grant
  • 12185767
  • Patent Number
    12,185,767
  • Date Filed
    Friday, November 4, 2022
    2 years ago
  • Date Issued
    Tuesday, January 7, 2025
    5 days ago
  • Inventors
  • Original Assignees
    • Trillium Medical Products, LLC (Lake Worth, FL, US)
  • Examiners
    • Quinn; Richale L
    Agents
    • McHale & Slavin, P.A.
Abstract
An infused undergarment device for use as a delivery device for colonizing the vagina with Lactobacillus in patients who test positive for or report symptoms of vaginitis. The infused undergarment employs a sponge impregnated with Lactobacillus crispatus Freeze Dried Powder. The sponge, having channels to direct the powder, is held in place by a mesh fabric sewn into the groin portion of the undergarment, which allows the c n ay delivery of the powder. The undergarment may also be used to help maintain normal flora of the vagina in the absence of symptoms in a prophylactic manner to prevent future infection. The undergarment is sealed in an opaque aluminum foil package to prevent light and environment air from degrading effectiveness.
Description
FIELD OF THE INVENTION

The present disclosure is directed to the field of infection treatment and, in particular, to an infused undergarment that can be employed to increase colonization of Lactobacillus in women with vaginal infections.


BACKGROUND OF THE INVENTION

Vaginitis, infection or inflammation of the vagina or vulva, is a common issue recognized in gynecology offices all over the country. Whether originating from bacterial or yeast overgrowth, patients complain of discharge, itching, burning, or embarrassing odor. In many cases women report recurrent infections with no recourse for effective long term treatment or prevention. Currently, the best clinical advice is for these women to wear a cotton undergarment, send a culture, and a prescription for antibiotic or antifungal is given. However, this course of action is treating symptoms and does not resolve the underlying cause. When patients are presented with symptoms, cultures are sent to a laboratory for both pathologic organisms and normal flora bacteria. Anecdotal evidence shows a strong pattern can be seen in those with recurring yeast or bacterial infections, namely these women lacked colonization with Lactobacillus.


At present, there are no formulations of probiotics that are designed to colonize the vagina directly. There are researchers attempting to develop a vaginal tablet; however, the use of a tablet will require FDA approval, a prescription from a physician to obtain it, and the task of the patient inserting themselves correctly.


It is widely accepted that the presence of Lactobacillus in the vagina plays a key role in maintaining pH levels, and serves an active role in host defense mechanisms against pathologic infection. By secreting hydrogen peroxide and antibacterial/antifungal molecules, Lactobacillus species have been shown to inhibit growth of Candida and bacteria known to cause bacterial vaginosis. In addition, vaginosis has been associated with decreased colony counts of Lactobacillus, suggesting that lack of colonization may lead to increased susceptibility to infection.


Products containing Lactobacillus are available on the market. However, they are sold in the form of oral tablets which are meant to travel the gut before attempting to reach the vaginal target via a contaminated route.


SUMMARY OF THE INVENTION

Disclosed is a delivery device for use in colonizing the vagina with Lactobacillus in patients who test positive for or report symptoms of vaginitis. The device consists of an infused undergarment employing a sponge impregnated with Lactobacillus crispatus Freeze Dried Powder. The sponge, having channels to direct the powder, is held in place by a mesh fabric sewn into the groin portion of the garment, which allows the one way delivery of the powder. The infused undergarment may also be used to help maintain normal flora of the vagina in the absence of symptoms in a prophylactic manner to prevent future infection. The infused undergarment is sealed in an opaque aluminum foil package to prevent light and environment air from degrading the effectiveness of the infused undergarment.


An objective of the invention is to colonize the vagina with Lactobacillus crispatus bacterium using a wearable garment impregnated with Lactobacillus powder.


Another objective of the invention is to provide a probiotic undergarment to provide women with symptomatic relief of symptoms such as itching, burning, discharge, and odor.


Still another objective of the invention is to provide a probiotic undergarment that can result in resolution of bacterial and yeast infection without use of supplemental antibiotics or antifungals.


Another objective of the invention is to use the Lactobacillus garment for colonizing the vagina, alleviating symptoms of vaginitis, and treating vaginitis with and without traditional antibiotics/antifungal drugs.


An advantage of an infused undergarment of the invention is that the product provides a noninvasive treatment that administers the probiotic directly to the vulva and vagina. The infused undergarment does not require any insertion of tablets or gels. As the product is not inserted into the body, the patient will not need to have a prescription for the treatment. The active component is composed solely of Lactobacillus, making allergic reaction less likely.


Another advantage of the infused undergarment of the invention is that there is no latex in the device, avoiding the risk of latex allergy.


Yet still another advantage of an infused undergarment of the invention is that it allows direct contact with an affected area, which is more effective than taking an oral supplement that has to pass through the digestive system.


Other objectives and advantages of this invention will become apparent from the following description taken in conjunction with any accompanying drawings wherein are set forth, by way of illustration and example, certain embodiments of this invention. Any drawings contained herein constitute a part of this specification, include exemplary embodiments of the present invention, and illustrate various objects and features thereof.





BRIEF DESCRIPTION OF THE FIGURES


FIG. 1A is a front plane view of the infused undergarment of the instant invention;



FIG. 1B is a top view thereof;



FIG. 2A is a top view of the receptacle;



FIG. 2B is a side view thereof;



FIG. 3A is a top perspective view of the polyurethane foam member having a diamond shaped upper surface for powder distribution;



FIG. 3B is a cross sectional side view thereof; and



FIG. 4 is a top view of the foam member having a honeycomb shaped upper surface for powder distribution.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

While the present invention is susceptible of embodiments in various forms, there is shown in the drawings and will hereinafter be described a presently preferred embodiment with the understanding that the present disclosure is to be considered an exec exemplification of the invention and is not intended to limit the invention to the specific embodiments illustrated.


It is widely known that the presence of Lactobacillus in the vagina plays a key role in maintaining pH levels, and serves an active role in protecting against infection. Lactobacillus species have been shown to inhibit growth of Candida and bacteria known to cause bacterial vaginosis. In addition, vaginosis has been associated with decreased colony counts of Lactobacillus, suggesting that lack of colonization may lead to increased susceptibility to infection.


Referring to FIGS. 1A and 1B, illustrated is an infused undergarment 10 having a preferred use to increase colonization of Lactobacillus in women with vaginal infections. The undergarment 10 is formed with a waist opening 12 at the top 14 of the undergarment 10. A left leg opening 16 is formed at the bottom left 18 of the undergarment 10, and a right leg opening 20 is formed at the bottom right 22 of the undergarment 10. A crotch portion 25 is positioned between the left leg opening 18 and the right leg opening 20. The infused undergarment 10 is preferably in the shape of a panty, wherein a receptacle 26 is placed in the crotch portion 25 along the inner surface 28 of the panty. While a panty is depicted, the receptacle can be constructed and adopted to work in an undergarment as small as a thong. The undergarment 10 is constructed of a microfiber material having quick drying and moisture wicking properties. In one embodiment, the undergarment is constructed of a microfiber material having a 50% Polyester and 50% Elasterell blended fabric. In another embodiment, the undergarment is constructed of a microfiber material comprising 25% to 50% Elastane. In one embodiment, the receptacle 26 is formed integral with the undergarment 10. In another embodiment, the receptacle 26 is attached to the inner surface 28 of the crotch area.


Referring to FIGS. 2A and 2B, depicted is the receptacle 26 having a substantially rectangular shape with an upper wall 30 and a lower wall 32 to create a cavity therebetween 34; the upper wall 30 including an elongated opening extending a length between the left and right leg openings 16, 20. Should the receptacle 26 not be formed integral to the undergarment 10, the preferred material remains the same as the undergarment, wherein the receptacle 26 is attached by thread.


Referring to FIGS. 3A and 3B, depicted is a polyurethane foam member 40 to be placed within the receptacle 26. The foam member 40 is an open cell powder-absorbent pad, preferably polyurethane flexible foam made of isocyanates and polyether or polyester polyols. The foam member 40 has an upper surface 42 and a lower surface 44; the upper surface 42 having grooves 46 arranged in a diamond pattern with a depth between 1 mm and 3 mm. One skilled in the art will recognize that the pattern need not be limited to a diamond shape, rather a pattern that has grooves forming a depth is used to hold the powder wherein leg movement operates to help move the powder. For instance in another embodiment a foam member 50 may have an upper surface 52 having grooves 54 with a depth between 1 mm and 3 mm forming a hexagonal or honeycomb pattern 56 as depicted in FIG. 4.


A predetermined amount of Lactobacillus crispatus freeze dried powder is infused in the foam member 40. The Lactobacillus crispatus freeze dried powder is transferred through the groove 46 for dispersion through an elongated opening 35. The foam member 40 and receptacle 26 cause movement of the powder to be distributed along the grooves 46 and pass through the elongated opening 35 as a result of leg movement by the individual wearing the undergarment 10. The process allows woman to increase the colonization of Lactobacillus in addressing vaginal infections comprising the steps of:


Step 1: providing an undergarment 10 defined by a waist opening 12 at the top 14 of the undergarment, a left leg opening 16 at the bottom left 18 of the undergarment, a right leg opening 20 at the bottom right 22 of the undergarment, and a crotch portion 25 in between the left leg opening 16 and the right leg opening 20, and having a receptacle 26 formed integral or attached to said crotch section 25. The receptacle 26 having an elongated opening 35 extending a length between said left leg opening 16 and right leg opening 20.


Step 2: inserting a polyurethane foam member 40 having a predetermined amount of Lactobacillus crispatus Freeze Dried Powder infused in the foam member 40 into said receptacle 26.


Step 3: positioning said undergarment 10 on a woman's torso, wherein the individual wearing said undergarment 10 is treated with a release of said Lactobacillus crispatus freeze dried powder through said elongated opening 35 during leg movement for treatment of vaginal infections.


Step 4: repeating Steps 1-3 for ten consecutive days.


The foam member 40 with the Lactobacillus crispatus freeze dried powder operates in combination with grooves to expel the powder from the receptacle 26 through the opening 35. The leg movement of the individual allows movement of powder within the receptacle 26 and what could be described as a pump. The Lactobacillus crispatus freeze dried powder is flowable with good handling and packaging characteristics and formulate to retain functional attributes of the native biomolecule. In the preferred process stated above, the treatment is sold as a kit with ten individual packages of undergarments. The infused undergarment is stored in a sealed aluminum foil package. Sealing of the undergarment allows ease of use by simply opening of the package. The undergarments can be cleaned and reuse wherein the infused foam replacement member would be provided in sealed aluminum packages and inserted into a receptacle of undergarment.


The use of the word “a” or “an” when used conjunction with the term “comprising” in the claims and/or the specification may mean “one,” but it is also consistent with the meaning of “one or more” or “at least one.” The use of the term “or” in the claims is used to mean “and/or” unless explicitly indicated to refer to alternatives only or the alternative are mutually exclusive, although the disclosure supports a definition that refers to only alternatives and “and/or.”


The terms “comprise” (and any form of comprise, such as “comprises” and “comprising”), “have” (and any form of have, such as “has” and “having”), “include” (and any form of include, such as “includes” and “including”) and “contain” (and any form of contain, such as “contains” and “containing”) are open-ended linking verbs. As a result, a device that “comprises,” “has,” “includes” or “contains” one or more steps or elements, possesses those one or more steps or elements, but is not limited possessing only those one more elements. Likewise, a step of a method or an element of a device that “comprises,” “has,” “includes” or “contains” one or more features, possesses those one or more features, but is not limited to possessing only those one or more features. Furthermore, a device or structure that is configured in a certain way is configured in at least that way, but may also be configured in ways that are not listed.


It is to be understood that while a certain form of the invention is illustrated, it is not to be limited to the specific form or arrangement herein described and shown. It will be apparent to those skilled in the art that various changes may be made without departing from the scope of the invention and the invention is not to be considered limited to what is shown and described in the specification and any drawings/figures included herein.


One skilled in the art will readily appreciate that the present invention is well adapted to carry out the objectives and obtain the ends and advantages mentioned, as well as those inherent therein. The embodiments, methods, procedures, and techniques described herein are presently representative of the preferred embodiments, are intended to be exemplary, and are not intended as limitations on the scope. Changes therein and other uses will occur to those skilled in the art which are encompassed within the spirit of the invention and are defined by the scope of the appended claims. Although the invention has been described in connection with specific preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. Indeed, various modifications of the described modes for carrying out the invention which are obvious to those skilled in the art are intended to be within the scope of the following claims.

Claims
  • 1. An infused undergarment comprising: an undergarment defined by a waist opening at the top of the undergarment, a left leg opening at the bottom left of the undergarment, a right leg opening at the bottom right of the undergarment, and a crotch portion in between the left leg opening and the right leg opening;a receptacle formed in said crotch section, said receptacle having an elongated opening extending a length between said left and right leg opening;a polyurethane open cell foam member positioned within said receptacle, said polyurethane foam member having a grooved surface constructed and arranged to hold powder within the grooved surface, each groove having a depth between 1 mm and 3 mm; anda predetermined amount of medicated Powder infused in said polyurethane foam member grooved surface;wherein an individual wearing said undergarment is treated with a release of said medicated Powder from said form member as a result of leg movement.
  • 2. The infused undergarment according to claim 1 wherein foam pad is further defined as polyurethane flexible foam made of isocyanates and polyether or polyester polyols.
  • 3. The infused undergarment according to claim 2 wherein said grooves are arranged in a pattern selected from the group consisting of diamond or honeycomb.
  • 4. The infused undergarment according to claim 1 wherein said infused foam member is stored in a sealed aluminum foil package.
  • 5. An infused undergarment to increase colonization of Lactobacillus in women with vaginal infections comprising: an undergarment defined by a front waist opening at the top of the undergarment, a left leg opening at the bottom left of the undergarment, a right leg opening at the bottom right of the undergarment, and a crotch portion in between the left leg opening and the right leg opening;a receptacle formed in said crotch section, said receptacle having an elongated opening extending a length between said left and right leg openings;a polyurethane open cell foam member having a grooved surface constructed and arranged to hold Lactobacillus Crispatus Freeze Dried Powder, each said groove having a depth between 1 mm and 3 mm positioned within said receptacle; anda predetermined amount of Lactobacillus Crispatus Freeze Dried Powder infused in said polyurethane foam member grooved surface;wherein an individual wearing said undergarment is treated with a release of said Lactobacillus Crispatus Freeze Dried Powder from said foam member by said individual wearing the undergarment through leg movement for treatment of vaginal infections.
  • 6. The infused undergarment according to claim 5, wherein said undergarment comprises a microfiber material for quick drying and moisture wicking.
  • 7. The infused undergarment according to claim 6, Wherein said microfiber material is 50% Polyester and 50% Elasterell.
  • 8. The infused undergarment according to claim 6 wherein said microfiber material comprises 25% to 50% Elastane.
  • 9. The infused undergarment according to claim 2 wherein said undergarment is a panty.
RELATED APPLICATION

In accordance with 37 C.F.R. § 1.76, a claim, of priority is included in an Application Data Sheet filed concurrently herewith. Accordingly, the present invention claims priority based upon U.S. Provisional Patent Application No. 63/276,331, filed Nov. 5, 2021, entitled “INFUSED UNDERGARMENT”, the contents of which are incorporated herein by reference.

US Referenced Citations (96)
Number Name Date Kind
2102359 Frieman Dec 1937 A
2418907 Schreiber Apr 1947 A
2494292 Frazer Jan 1950 A
2595507 Beck May 1952 A
2719976 Sussman Oct 1955 A
3088462 Muto May 1963 A
3312981 McGuire Apr 1967 A
3490454 Goldfarb Jan 1970 A
3613686 De Woskin Oct 1971 A
3749095 Toyama Jul 1973 A
3875942 Roberts Apr 1975 A
3881490 Whitehead May 1975 A
4244059 Pflaumer Jan 1981 A
4421512 Papajohn Dec 1983 A
4731063 Newkirk Mar 1988 A
4790836 Brecher Dec 1988 A
4984304 Brown Jan 1991 A
5241710 Lockhart Sep 1993 A
5416929 Braunstein May 1995 A
5490847 Correa Feb 1996 A
6015816 Kostyniak Jan 2000 A
6041446 Braunstein Mar 2000 A
6409712 Dutari Jun 2002 B1
7322966 Deerin Jan 2008 B1
7601882 Farbrot Oct 2009 B2
7752681 Michel Jul 2010 B2
7858840 Hisanaka Dec 2010 B2
8552249 Akinsanya Oct 2013 B2
8575419 Di Virgilio Nov 2013 B2
8935813 O'Leary Jan 2015 B2
8993832 Kuroda Mar 2015 B2
9003571 Lewis-Williams Apr 2015 B1
9173782 Takken Nov 2015 B2
9370451 Hardy Jun 2016 B2
10420854 Raver Sep 2019 B2
10765564 Lee Sep 2020 B2
11298278 Font Caselles Apr 2022 B2
11364156 Zhao Jun 2022 B2
11850820 Liu Dec 2023 B2
20040064120 Berba Apr 2004 A1
20040122386 Mocadlo Jun 2004 A1
20040122396 Maldonado Jun 2004 A1
20060101558 Coleman May 2006 A1
20070135009 Liao Jun 2007 A1
20070287981 Roe Dec 2007 A1
20080096001 Emden Apr 2008 A1
20080109945 Xia May 2008 A1
20090118574 Stephenson May 2009 A1
20100152687 Carlozzi Jun 2010 A1
20100249736 Png Sep 2010 A1
20110023216 O'Leary Feb 2011 A1
20120255103 Evenstad Oct 2012 A1
20130108599 Comeaux May 2013 A1
20130158635 Federico Jun 2013 A1
20130281945 Gallo Oct 2013 A1
20140295134 Wood Oct 2014 A1
20140316363 You Oct 2014 A1
20140358092 Koumans Dec 2014 A1
20140378936 Coates Dec 2014 A1
20150038040 Gabbay Feb 2015 A1
20150133017 Liao May 2015 A1
20150328060 Bagger-Sjöbäck Nov 2015 A1
20150328061 Bagger-Sjöbäck Nov 2015 A1
20150354101 Liao Dec 2015 A1
20160030249 Caneppele Feb 2016 A1
20160338881 Hyppolite Nov 2016 A1
20170258650 Rosati Sep 2017 A1
20170333260 Garner Nov 2017 A1
20180132541 Wittstadt May 2018 A1
20180318148 Joshi Nov 2018 A1
20190070229 Choi Mar 2019 A1
20190082748 Mazourik Mar 2019 A1
20190116888 White Apr 2019 A1
20190352445 Zhao Nov 2019 A1
20190380886 Hammond Dec 2019 A1
20200000155 Etienne Jan 2020 A1
20200008986 Hopkins Jan 2020 A1
20200063077 Nolan Feb 2020 A1
20200068958 Yabarafundi Mar 2020 A1
20200171107 Parks Jun 2020 A1
20210016243 Yonce Jan 2021 A1
20210030605 Kajanthan Feb 2021 A1
20210146000 Dagger May 2021 A1
20210298296 Fayed Sep 2021 A1
20210338486 Dagger Nov 2021 A1
20210338749 Finlayson Nov 2021 A1
20210352970 Monaco Nov 2021 A1
20220249301 Wirsig Aug 2022 A1
20220378624 Agud Dec 2022 A1
20220408848 Krupa Dec 2022 A1
20220408850 Laurin Dec 2022 A1
20230050850 Miller Feb 2023 A1
20230059401 Mellos Feb 2023 A1
20230081210 Gaffney Mar 2023 A1
20230149481 Finlayson May 2023 A1
20230228011 Martin Jul 2023 A1
Related Publications (1)
Number Date Country
20230141346 A1 May 2023 US
Provisional Applications (1)
Number Date Country
63276331 Nov 2021 US